Videos

Tumor Treating Fields for Brain Metastases in Lung Cancer Boost Quality of Life With Some Trade-Offs

June 11th 2024, 9:00pm

Video

For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.

Patients With Stage 3 Melanoma Should Discuss Adjuvant Therapy

June 7th 2024, 9:00pm

Video

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.

Trodelvy Improves Quality of Life Over Chemo in TNBC

June 6th 2024, 9:00pm

Video

Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.

An Overview of Potential Treatment Adverse Effects

June 5th 2024, 7:55pm

Video

An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.

What to Know Before Starting Your CLL Treatment

June 5th 2024, 7:45pm

Video

Josie Montegaard, MSN, AGPCNP-BC, provides clinical insights on her approach to counseling patients who are receiving treatment for chronic lymphocytic leukemia.

Grief Advocate Explains the Difference Between Forced Joy and Toxic Positivity

June 5th 2024, 3:00pm

Video

After a cancer diagnosis, toxic positivity can be unhelpful, though forced joy may bring light to a difficult situation, a survivor and advocate said.

An Expert Breakdown of SurVaxM, the Novel Brain Cancer Vaccine

June 3rd 2024, 3:00pm

Video

SurVaxM, which is being studied in gliobastoma, targets a certain protein that is found on the brain cancer cells.

Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer

June 2nd 2024, 5:00pm

Video

Presurgical paclitaxel, Herceptin and Perjeta showed “incredible efficacy” in treatment of HER2-positive breast cancer.

Rybrevant Plus Leclaza Has ‘Very Potent Activity’ in Lung Cancer Subset

June 1st 2024, 9:02pm

Video

Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.

Newer Combinations for the Treatment of CLL

May 29th 2024, 4:15pm

Video

Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.